DOUTOR NICHIRES Holdings Co., Ltd. (TYO:3087)
Japan · Delayed Price · Currency is JPY 2,957.00
-19.00 (-0.64%)
Feb 13, 2026, 2:44 PM JST
DOUTOR NICHIRES Holdings Income Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 |
| 156,128 | 148,822 | 140,625 | 126,864 | 109,363 | 96,141 | |
Revenue Growth (YoY) | 6.34% | 5.83% | 10.85% | 16.00% | 13.75% | -26.72% |
Cost of Revenue | 63,853 | 59,201 | 56,436 | 52,094 | 45,048 | 40,366 |
Gross Profit | 92,275 | 89,621 | 84,189 | 74,770 | 64,315 | 55,775 |
Selling, General & Admin | 82,671 | 80,023 | 76,866 | 71,800 | 66,098 | 60,095 |
Operating Expenses | 82,671 | 80,023 | 76,866 | 71,800 | 66,098 | 60,095 |
Operating Income | 9,604 | 9,598 | 7,323 | 2,970 | -1,783 | -4,320 |
Interest Expense | -29 | -27 | -17 | -15 | -13 | -15 |
Interest & Investment Income | 69 | 46 | 34 | 29 | 30 | 33 |
Earnings From Equity Investments | -39 | -51 | -19 | -7 | -21 | -30 |
Currency Exchange Gain (Loss) | 214 | -52 | 269 | 376 | 162 | 51 |
Other Non Operating Income (Expenses) | 85 | 99 | 109 | 111 | 145 | 102 |
EBT Excluding Unusual Items | 9,904 | 9,613 | 7,699 | 3,464 | -1,480 | -4,179 |
Gain (Loss) on Sale of Investments | - | - | 45 | - | - | - |
Gain (Loss) on Sale of Assets | 5 | 9 | 27 | 6 | 1 | 2 |
Asset Writedown | -696 | -598 | -920 | -1,302 | -3,160 | -3,533 |
Other Unusual Items | 215 | 277 | 596 | 1,855 | 8,066 | -1,224 |
Pretax Income | 9,428 | 9,301 | 7,447 | 4,023 | 3,427 | -8,934 |
Income Tax Expense | 2,546 | 2,385 | 1,911 | 562 | 2,168 | 2,012 |
Earnings From Continuing Operations | 6,882 | 6,916 | 5,536 | 3,461 | 1,259 | -10,946 |
Minority Interest in Earnings | -34 | -36 | -45 | -32 | -38 | -33 |
Net Income | 6,848 | 6,880 | 5,491 | 3,429 | 1,221 | -10,979 |
Net Income to Common | 6,848 | 6,880 | 5,491 | 3,429 | 1,221 | -10,979 |
Net Income Growth | 8.61% | 25.30% | 60.13% | 180.83% | - | - |
Shares Outstanding (Basic) | 42 | 44 | 44 | 44 | 44 | 44 |
Shares Outstanding (Diluted) | 42 | 44 | 44 | 44 | 44 | 44 |
Shares Change (YoY) | -4.12% | -0.31% | -0.56% | 0.01% | 0.03% | 0.05% |
EPS (Basic) | 159.89 | 156.95 | 124.88 | 77.55 | 27.61 | -248.37 |
EPS (Diluted) | 159.89 | 156.95 | 124.88 | 77.55 | 27.61 | -248.37 |
EPS Growth | 11.15% | 25.69% | 61.03% | 180.82% | - | - |
Free Cash Flow | - | 6,491 | 7,327 | 142 | 10,429 | -7,932 |
Free Cash Flow Per Share | - | 148.08 | 166.63 | 3.21 | 235.87 | -179.44 |
Dividend Per Share | 54.000 | 50.000 | 40.000 | 30.000 | 26.000 | 24.000 |
Dividend Growth | 25.58% | 25.00% | 33.33% | 15.38% | 8.33% | -29.41% |
Gross Margin | - | 60.22% | 59.87% | 58.94% | 58.81% | 58.01% |
Operating Margin | 6.15% | 6.45% | 5.21% | 2.34% | -1.63% | -4.49% |
Profit Margin | 4.39% | 4.62% | 3.91% | 2.70% | 1.12% | -11.42% |
Free Cash Flow Margin | - | 4.36% | 5.21% | 0.11% | 9.54% | -8.25% |
EBITDA | 14,468 | 14,202 | 11,580 | 6,883 | 2,401 | 197 |
EBITDA Margin | - | 9.54% | 8.24% | 5.42% | 2.20% | 0.21% |
D&A For EBITDA | 4,864 | 4,604 | 4,257 | 3,913 | 4,184 | 4,517 |
EBIT | 9,604 | 9,598 | 7,323 | 2,970 | -1,783 | -4,320 |
EBIT Margin | - | 6.45% | 5.21% | 2.34% | -1.63% | -4.49% |
Effective Tax Rate | - | 25.64% | 25.66% | 13.97% | 63.26% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.